Molecular Epidemiology of Enteroviruses Detected at the Virology Laboratory of Brest University Hospital During the Period 2018-2024: Retrospective Analysis of an Atypical Meningitis Epidemic in 2024 (BrEcho9Men)
BrEcho9Men
1 other identifier
observational
270
1 country
1
Brief Summary
This study is being done to learn more about enterovirus infections detected in the cerebrospinal fluid of patients at CHU de Brest. Researchers will analyze medical records and laboratory data collected between 2018 and 2024. They will look at how these infections present in patients, and whether a specific virus type, called Echo-9, may be associated with different clinical features or represent an emerging variant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2025
CompletedFirst Submitted
Initial submission to the registry
April 3, 2025
CompletedFirst Posted
Study publicly available on registry
April 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2025
CompletedApril 10, 2025
March 1, 2025
8 months
April 3, 2025
April 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Phylogenetic analysis of Echo-9 strains detected between 2018 and 2024
Molecular characterization and phylogenetic comparison of Echo-9 strains detected at CHU de Brest and throughout France between January 1, 2018 and December 31, 2024, to identify a possible emerging variant.
January 1, 2018 to December 31, 2024
Secondary Outcomes (3)
Temporal distribution of enterovirus infections documented at CHU de Brest
January 1, 2018 to December 31, 2024
Clinical characteristics of enterovirus-positive CSF cases
January 1, 2018 to December 31, 2024
Biological characteristics of enterovirus-positive CSF samples
January 1, 2018 to December 31, 2024
Eligibility Criteria
Patients with a cerebrospinal fluid sample positive for enterovirus by RT-PCR performed at the virology laboratory of CHU de Brest between 2018 and 2024. This includes patients managed at CHU de Brest as well as at partner hospitals in Finistère (France) whose samples were processed centrally.
You may qualify if:
- Cerebrospinal fluid (CSF) sample positive for enterovirus by RT-PCR between January 1, 2018 and December 31, 2024 , performed at the virology laboratory of CHU de Brest.
- No documented opposition to the use of medical data for research purposes.
You may not qualify if:
- Patients under legal protection (guardianship, curatorship, etc.)
- Refusal to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu Brest
Brest, 29200, France
Biospecimen
Clinical specimens tested positive for enteroviruses by RT-PCR will be retained. These include cerebrospinal fluid (CSF), throat swabs, stool samples, and nasopharyngeal swabs collected as part of routine care.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 3, 2025
First Posted
April 10, 2025
Study Start
March 1, 2025
Primary Completion
October 31, 2025
Study Completion
October 31, 2025
Last Updated
April 10, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Data will be available beginning three years and ending fifteen years following the final study report completion
- Access Criteria
- Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement
All collected data that underlie results in a publication